PatchSiren

PatchSiren cyber security CVE debrief

CVE-2022-47986 IBM CVE debrief

CVE-2022-47986 is a code execution vulnerability affecting IBM Aspera Faspex. CISA added it to the Known Exploited Vulnerabilities catalog on 2023-02-21 and marked it as associated with known ransomware campaign use. Based on the supplied sources, the safest response is to treat this as an urgent patching item and follow IBM’s update guidance as referenced by CISA.

Vendor
IBM
Product
Aspera Faspex
CVSS
CRITICAL 9.8
CISA KEV
Listed
Original CVE published
2023-02-21
Original CVE updated
2023-02-21
Advisory published
2023-02-21
Advisory updated
2023-02-21

Who should care

IBM Aspera Faspex administrators, security operations teams, vulnerability management teams, and incident response teams responsible for internet-facing or business-critical file transfer systems.

Technical summary

The supplied corpus identifies CVE-2022-47986 as an IBM Aspera Faspex code execution vulnerability. CISA lists it in the Known Exploited Vulnerabilities catalog, which indicates confirmed exploitation in the wild. CISA also flags known ransomware campaign use. No additional technical details are provided in the supplied sources, so public guidance should stay focused on remediation and exposure reduction rather than speculative mechanics.

Defensive priority

Urgent. KEV inclusion and known ransomware campaign use make this a high-priority remediation item, especially for any production or externally accessible IBM Aspera Faspex deployment.

Recommended defensive actions

  • Identify all IBM Aspera Faspex instances and confirm current versions.
  • Apply IBM-recommended updates or mitigations as referenced by CISA as soon as possible.
  • Treat exposed or production instances as highest priority and accelerate patch validation.
  • Verify whether any systems were accessible during the period before remediation and review relevant security logs.
  • If immediate patching is not possible, apply compensating controls consistent with vendor guidance and reduce exposure where feasible.
  • Track remediation against the CISA KEV due date of 2023-03-14 for this entry.

Evidence notes

The supplied source corpus contains CISA KEV metadata only, with the vulnerability named as "IBM Aspera Faspex Code Execution Vulnerability." CISA lists vendorProject IBM, product Aspera Faspex, dateAdded 2023-02-21, dueDate 2023-03-14, and knownRansomwareCampaignUse Known. The corpus also references the official CVE record and NVD detail page, but no additional technical or version-specific details were supplied.

Sources and references

Verified primary and authoritative sources

  • CVE-2022-47986 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2022-47986

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2022-47986 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2022-47986

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

  • CISA Known Exploited Vulnerabilities catalog

    Publisher, destination, and source semantics verified

    URL: https://www.cisa.gov/known-exploited-vulnerabilities-catalog

    Cybersecurity and Infrastructure Security Agency - Official CISA catalog of vulnerabilities known to be exploited in the wild.

Supplemental references

  • Source item URL

    Unverified legacy reference

    URL: https://www.cisa.gov/sites/default/files/feeds/known_exploited_vulnerabilities.json

    cisa_kev

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.